Drug Side Effects
Search
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III
was reported 18 times
These drug classes are most commonly taken by patients reporting PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III:
#
Drug
Count
0
Folate Analog Metabolic Inhibitor [EPC]
8
1
Alkylating Drug [EPC]
7
2
Corticosteroid [EPC]
7
3
CD20-directed Cytolytic Antibody [EPC]
6
4
Topoisomerase Inhibitor [EPC]
5
5
Calcium Channel Blocker [EPC]
1
6
Dihydropyridine Calcium Channel Blocker [EPC]
1
7
HMG-CoA Reductase Inhibitor [EPC]
1
8
Insulin Analog [EPC]
1
9
Loop Diuretic [EPC]
1
10
Tumor Necrosis Factor Blocker [EPC]
1